179 related articles for article (PubMed ID: 26610428)
1. pH-susceptibility of HLA-DO tunes DO/DM ratios to regulate HLA-DM catalytic activity.
Jiang W; Strohman MJ; Somasundaram S; Ayyangar S; Hou T; Wang N; Mellins ED
Sci Rep; 2015 Nov; 5():17333. PubMed ID: 26610428
[TBL] [Abstract][Full Text] [Related]
2. HLA-DM catalytically enhances peptide dissociation by sensing peptide-MHC class II interactions throughout the peptide-binding cleft.
Reyes-Vargas E; Barker AP; Zhou Z; He X; Jensen PE
J Biol Chem; 2020 Mar; 295(10):2959-2973. PubMed ID: 31969393
[TBL] [Abstract][Full Text] [Related]
3. HLA-DM targets the hydrogen bond between the histidine at position beta81 and peptide to dissociate HLA-DR-peptide complexes.
Narayan K; Chou CL; Kim A; Hartman IZ; Dalai S; Khoruzhenko S; Sadegh-Nasseri S
Nat Immunol; 2007 Jan; 8(1):92-100. PubMed ID: 17143275
[TBL] [Abstract][Full Text] [Related]
4. Functional HLA-DM on the surface of B cells and immature dendritic cells.
Arndt SO; Vogt AB; Markovic-Plese S; Martin R; Moldenhauer G; Wölpl A; Sun Y; Schadendorf D; Hämmerling GJ; Kropshofer H
EMBO J; 2000 Mar; 19(6):1241-51. PubMed ID: 10716924
[TBL] [Abstract][Full Text] [Related]
5. Evaluating the Role of HLA-DM in MHC Class II-Peptide Association Reactions.
Yin L; Maben ZJ; Becerra A; Stern LJ
J Immunol; 2015 Jul; 195(2):706-16. PubMed ID: 26062997
[TBL] [Abstract][Full Text] [Related]
6. The role of H2-O and HLA-DO in major histocompatibility complex class II-restricted antigen processing and presentation.
Alfonso C; Liljedahl M; Winqvist O; Surh CD; Peterson PA; Fung-Leung WP; Karlsson L
Immunol Rev; 1999 Dec; 172():255-66. PubMed ID: 10631951
[TBL] [Abstract][Full Text] [Related]
7. DM and DO shape the repertoire of peptide-MHC-class-II complexes.
Karlsson L
Curr Opin Immunol; 2005 Feb; 17(1):65-70. PubMed ID: 15653313
[TBL] [Abstract][Full Text] [Related]
8. Distinct editing functions of natural HLA-DM allotypes impact antigen presentation and CD4
Álvaro-Benito M; Morrison E; Ebner F; Abualrous ET; Urbicht M; Wieczorek M; Freund C
Cell Mol Immunol; 2020 Feb; 17(2):133-142. PubMed ID: 30467419
[TBL] [Abstract][Full Text] [Related]
9. How HLA-DM affects the peptide repertoire bound to HLA-DR molecules.
Vogt AB; Kropshofer H; Hämmerling GJ
Hum Immunol; 1997 May; 54(2):170-9. PubMed ID: 9297535
[TBL] [Abstract][Full Text] [Related]
10. Secondary structure composition and pH-dependent conformational changes of soluble recombinant HLA-DM.
Busch R; Reich Z; Zaller DM; Sloan V; Mellins ED
J Biol Chem; 1998 Oct; 273(42):27557-64. PubMed ID: 9765288
[TBL] [Abstract][Full Text] [Related]
11. A role for HLA-DO as a co-chaperone of HLA-DM in peptide loading of MHC class II molecules.
Kropshofer H; Vogt AB; Thery C; Armandola EA; Li BC; Moldenhauer G; Amigorena S; Hämmerling GJ
EMBO J; 1998 Jun; 17(11):2971-81. PubMed ID: 9606180
[TBL] [Abstract][Full Text] [Related]
12. The impact of the non-classical MHC proteins HLA-DM and HLA-DO on loading of MHC class II molecules.
Kropshofer H; Hämmerling GJ; Vogt AB
Immunol Rev; 1999 Dec; 172():267-78. PubMed ID: 10631952
[TBL] [Abstract][Full Text] [Related]
13. Forced expression of HLA-DM at the surface of dendritic cells increases loading of synthetic peptides on MHC class II molecules and modulates T cell responses.
Pezeshki AM; Côté MH; Azar GA; Routy JP; Boulassel MR; Thibodeau J
J Immunol; 2011 Jul; 187(1):74-81. PubMed ID: 21622867
[TBL] [Abstract][Full Text] [Related]
14. Formation of two peptide/MHC II isomers is catalyzed differentially by HLA-DM.
Belmares MP; Busch R; Mellins ED; McConnell HM
Biochemistry; 2003 Jan; 42(3):838-47. PubMed ID: 12534297
[TBL] [Abstract][Full Text] [Related]
15. The structure of HLA-DM, the peptide exchange catalyst that loads antigen onto class II MHC molecules during antigen presentation.
Mosyak L; Zaller DM; Wiley DC
Immunity; 1998 Sep; 9(3):377-83. PubMed ID: 9768757
[TBL] [Abstract][Full Text] [Related]
16. Editing of the HLA-DR-peptide repertoire by HLA-DM.
Kropshofer H; Vogt AB; Moldenhauer G; Hammer J; Blum JS; Hämmerling GJ
EMBO J; 1996 Nov; 15(22):6144-54. PubMed ID: 8947036
[TBL] [Abstract][Full Text] [Related]
17. Identification of the lateral interaction surfaces of human histocompatibility leukocyte antigen (HLA)-DM with HLA-DR1 by formation of tethered complexes that present enhanced HLA-DM catalysis.
Stratikos E; Mosyak L; Zaller DM; Wiley DC
J Exp Med; 2002 Jul; 196(2):173-83. PubMed ID: 12119342
[TBL] [Abstract][Full Text] [Related]
18. HLA-DM: arbiter conformationis.
Ferrante A
Immunology; 2013 Feb; 138(2):85-92. PubMed ID: 23113687
[TBL] [Abstract][Full Text] [Related]
19. HLA-DO as the optimizer of epitope selection for MHC class II antigen presentation.
Poluektov YO; Kim A; Hartman IZ; Sadegh-Nasseri S
PLoS One; 2013; 8(8):e71228. PubMed ID: 23951115
[TBL] [Abstract][Full Text] [Related]
20. "Chemical analogues" of HLA-DM can induce a peptide-receptive state in HLA-DR molecules.
Marin-Esteban V; Falk K; Rötzschke O
J Biol Chem; 2004 Dec; 279(49):50684-90. PubMed ID: 15381703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
